TP 53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients

被引:0
作者
Valeria Di Vuolo
Luigi Buonaguro
Francesco Izzo
Simona Losito
Gerardo Botti
Franco M Buonaguro
Maria Lina Tornesello
机构
[1] National Cancer Institute "Fond. Pascale",Molecular Biology and Viral Oncology and AIDS Ref. Centre
[2] National Cancer Institute,Hepato
[3] "Fond. Pascale",biliary Surgery Department
[4] National Cancer Institute,Department of Pathology
[5] "Fond. Pascale",undefined
来源
Infectious Agents and Cancer | / 6卷
关键词
Genetic Polymorphisms; 53 codon 72; SNP309; hepatocellular carcinoma;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 215 条
[1]  
Cho LY(2011)Coinfection of hepatitis B and C viruses and risk of hepatocellular carcinoma: systematic review and meta-analysis 2 Int J Cancer 128 176-184
[2]  
Yang JJ(1987)Changing incidence of hepatocellular carcinoma in Japan Cancer Res 47 4967-4972
[3]  
Ko KP(1998)Trends in primary liver cancer Lancet 351 214-215
[4]  
Park B(1997)Increase in primary liver cancer in the UK, 1979-94 Lancet 350 1142-1143
[5]  
Shin A(2003)The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update Ann Intern Med 139 817-823
[6]  
Lim MK(2009)Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection 1 Cancer Lett 286 9-14
[7]  
Okuda K(2006)Southern Europe as an example of interaction between various environmental factors: a systematic review of the epidemiologic evidence 1 Oncogene 25 3756-3770
[8]  
Fujimoto I(1990)A case-control study of hepatocellular carcinoma in Osaka, Japan Int J Cancer 45 231-236
[9]  
Hanai A(2002)The natural history of hepatocellular carcinoma Toxicology 181-182 39-42
[10]  
Urano Y(2008)Epidemiology of viral hepatitis infections in an area of southern Italy with high incidence rates of liver cancer Eur J Cancer 44 847-853